What’s being done to reduce post-op Afib? The BoxX-NoAF trial is studying surgical ablation + LAAE in at-risk patients during cardiac surgery. This first-of-its-kind, FDA-approved trial will enroll up to 960 patients across 75 sites worldwide.

Learn more: <a href="https://t.co/u6gQ1Ju1sR&quot; target="_blank">https://t.co/u6gQ1Ju1sR</a&gt;